Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

13th Jul 2009 10:34

RNS Number : 5504V
United Drug PLC
13 July 2009
 



SCHEDULE 11

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.

 

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

 

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

All relevant boxes should be completed in block capital letters

1

Name of the Issuer

UNITED DRUG PLC

2

State whether the notification relates to:

(i)  a transaction notified in accordance with Market Abuse Rules; 

(ii)  a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or

(iii) both (i) and (ii).

(iii)

3

Name of PERSON DISCHARGING MANAGERIAL RESPONSIBIILITY

MR. LUKE BREHONY

4

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

AS PER 3 ABOVE

6

Description of shares (including class) debentures or derivatives or financial instruments relating to shares

ORDINARY SHARES OF €0.05 EACH

7

Name of registered shareholder(s) and, if more than one, number of shares held by each of them

MR. LUKE BREHONY

8

State the nature of the transaction

ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO INTERIM DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2009 

9

Number of shares, debentures or financial instruments relating to shares acquired

31 ORDINARY SHARES OF €0.05 EACH

10

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.0000001%

11

Number of shares, debentures or financial instruments relating to shares disposed

 N/A

12

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

13

Price per share or value of transaction

31 @ €1.92

14

Date and place of transaction

10 JULY 2009

15

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

17,182 ORDINARY SHARES OF €0.05 EACH (0.00007%)

16

Date issuer informed of transaction

10 JULY 2009

If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:

17

Date of grant

18

Period during which or date on which it can be exercised

19

Total amount paid (if any) for grant of the option

20

Description of shares or debentures involved (class and number)

21

Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise

22

Total number of shares or debentures over which options are held following notification

23

Any additional information

N/A

24

Name of contact and telephone number for queries

 KAREN GEOGHEGAN (01-4637720)

Name and signature of duly designated officer of issuer responsible for making notification

_Karen Geoghegan___________________________________________________

Date of notification 13/07/2009

SCHEDULE 11

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.

 

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

 

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

All relevant boxes should be completed in block capital letters

1

Name of the Issuer

UNITED DRUG PLC

2

State whether the notification relates to:

(i)  a transaction notified in accordance with Market Abuse Rules; 

(ii)  a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or

(iii) both (i) and (ii).

(iii)

3

Name of PERSON DISCHARGING MANAGERIAL RESPONSIBILITY

MR. MICHAEL DUNNE

4

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

AS PER 3 ABOVE

6

Description of shares (including class) debentures or derivatives or financial instruments relating to shares

ORDINARY SHARES OF €0.05 EACH

7

Name of registered shareholder(s) and, if more than one, number of shares held by each of them

MR. MICHAEL DUNNE

8

State the nature of the transaction

ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO INTERIM DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2009 

9

Number of shares, debentures or financial instruments relating to shares acquired

320 ORDINARY SHARES OF €0.05 EACH

10

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.000001%

11

Number of shares, debentures or financial instruments relating to shares disposed

 N/A

12

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

13

Price per share or value of transaction

320 @ €1.92

14

Date and place of transaction

10 JULY 2009

15

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

34,711 ORDINARY SHARES OF €0.05 EACH (0.0002%)

16

Date issuer informed of transaction

10 JULY 2009

If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:

17

Date of grant

18

Period during which or date on which it can be exercised

19

Total amount paid (if any) for grant of the option

20

Description of shares or debentures involved (class and number)

21

Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise

22

Total number of shares or debentures over which options are held following notification

23

Any additional information

N/A

24

Name of contact and telephone number for queries

 KAREN GEOGHEGAN (01-4637720)

Name and signature of duly designated officer of issuer responsible for making notification

_Karen Geoghegan___________________________________________________

Date of notification 13/07/2009

SCHEDULE 11

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.

 

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

 

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

 

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

 

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

All relevant boxes should be completed in block capital letters

1

Name of the Issuer

UNITED DRUG PLC

2

State whether the notification relates to:

(i)  a transaction notified in accordance with Market Abuse Rules; 

(ii)  a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or

(iii) both (i) and (ii).

(iii)

3

Name of COMPANY SECRETARY

MS. KAREN GEOGHEGAN

4

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

AS PER 3 ABOVE

6

Description of shares (including class) debentures or derivatives or financial instruments relating to shares

ORDINARY SHARES OF €0.05 EACH

7

Name of registered shareholder(s) and, if more than one, number of shares held by each of them

MS. KAREN GEOGHEGAN

8

State the nature of the transaction

ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO INTERIM DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2009 

9

Number of shares, debentures or financial instruments relating to shares acquired

131 ORDINARY SHARES OF €0.05 EACH

10

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.0000006%

11

Number of shares, debentures or financial instruments relating to shares disposed

 N/A

12

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

13

Price per share or value of transaction

131 @ €1.92

14

Date and place of transaction

10 JULY 2009

15

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

14,251 ORDINARY SHARES OF €0.05 EACH (0.00006%)

16

Date issuer informed of transaction

10 JULY 2009

If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:

17

Date of grant

18

Period during which or date on which it can be exercised

19

Total amount paid (if any) for grant of the option

20

Description of shares or debentures involved (class and number)

21

Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise

22

Total number of shares or debentures over which options are held following notification

23

Any additional information

N/A

24

Name of contact and telephone number for queries

 KAREN GEOGHEGAN (01-4637720)

Name and signature of duly designated officer of issuer responsible for making notification

_Karen Geoghegan___________________________________________________

Date of notification 13/07/2009

SCHEDULE 11

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.

 

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

 

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

All relevant boxes should be completed in block capital letters

1

Name of the Issuer

UNITED DRUG PLC

2

State whether the notification relates to:

(i)  a transaction notified in accordance with Market Abuse Rules; 

(ii)  a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or

(iii) both (i) and (ii).

(iii)

3

Name of DIRECTOR

MR. KIERAN MCGOWAN

4

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

AS PER 3 ABOVE

6

Description of shares (including class) debentures or derivatives or financial instruments relating to shares

ORDINARY SHARES OF €0.05 EACH

7

Name of registered shareholder(s) and, if more than one, number of shares held by each of them

DAVYCREST NOMINEES

8

State the nature of the transaction

ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO INTERIM DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2009 

9

Number of shares, debentures or financial instruments relating to shares acquired

460 ORDINARY SHARES OF €0.05 EACH

10

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.000002%

11

Number of shares, debentures or financial instruments relating to shares disposed

 N/A

12

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

13

Price per share or value of transaction

460 @ €1.92

14

Date and place of transaction

10 JULY 2009

15

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

49,959 ORDINARY SHARES OF €0.05 EACH (0.0002%)

16

Date issuer informed of transaction

10 JULY 2009

If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:

17

Date of grant

18

Period during which or date on which it can be exercised

19

Total amount paid (if any) for grant of the option

20

Description of shares or debentures involved (class and number)

21

Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise

22

Total number of shares or debentures over which options are held following notification

23

Any additional information

N/A

24

Name of contact and telephone number for queries

 KAREN GEOGHEGAN (01-4637720)

Name and signature of duly designated officer of issuer responsible for making notification

_Karen Geoghegan___________________________________________________

Date of notification 13/07/2009

SCHEDULE 11

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.

 

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

 

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

All relevant boxes should be completed in block capital letters

1

Name of the Issuer

UNITED DRUG PLC

2

State whether the notification relates to:

(i)  a transaction notified in accordance with Market Abuse Rules; 

(ii)  a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or

(iii) both (i) and (ii).

(iii)

3

Name of DIRECTOR

MR. BARRY MCGRANE

4

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

AS PER 3 ABOVE

6

Description of shares (including class) debentures or derivatives or financial instruments relating to shares

ORDINARY SHARES OF €0.05 EACH

7

Name of registered shareholder(s) and, if more than one, number of shares held by each of them

MR. BARRY MCGRANE

8

State the nature of the transaction

ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO INTERIM DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2009

9

Number of shares, debentures or financial instruments relating to shares acquired

5,008 ORDINARY SHARES OF €0.05 EACH

10

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.00002%

11

Number of shares, debentures or financial instruments relating to shares disposed

 N/A

12

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

13

Price per share or value of transaction

5,008 @ €1.92

14

Date and place of transaction

10 JULY 2009

15

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

597,541 ORDINARY SHARES OF €0.05 EACH (0.003%)

16

Date issuer informed of transaction

10 JULY 2009

If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:

17

Date of grant

18

Period during which or date on which it can be exercised

19

Total amount paid (if any) for grant of the option

20

Description of shares or debentures involved (class and number)

21

Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise

22

Total number of shares or debentures over which options are held following notification

23

Any additional information

N/A

24

Name of contact and telephone number for queries

 KAREN GEOGHEGAN (01-4637720)

Name and signature of duly designated officer of issuer responsible for making notification

_Karen Geoghegan___________________________________________________

Date of notification 13/07/2009

SCHEDULE 11

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.

 

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

 

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

All relevant boxes should be completed in block capital letters

1

Name of the Issuer

UNITED DRUG PLC

2

State whether the notification relates to:

(i)  a transaction notified in accordance with Market Abuse Rules; 

(ii)  a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or

(iii) both (i) and (ii).

(iii)

3

Name of DIRECTOR

MR. PHILIP TOOMEY

4

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

AS PER 3 ABOVE

6

Description of shares (including class) debentures or derivatives or financial instruments relating to shares

ORDINARY SHARES OF €0.05 EACH

7

Name of registered shareholder(s) and, if more than one, number of shares held by each of them

MR. PHILIP TOOMEY & MRS. CATHERINE TOOMEY

8

State the nature of the transaction

ELECTION OF SCRIP DIVIDEND ALTERNATIVE OFFER RELATING TO INTERIM DIVIDEND FOR YEAR ENDING 30 SEPTEMBER 2009 

9

Number of shares, debentures or financial instruments relating to shares acquired

738 ORDINARY SHARES OF €0.05 EACH

10

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

0.000003%

11

Number of shares, debentures or financial instruments relating to shares disposed

 N/A

12

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

13

Price per share or value of transaction

738 @ €1.92

14

Date and place of transaction

10 JULY 2009

15

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

80,173 ORDINARY SHARES OF €0.05 EACH (0.0003%)

16

Date issuer informed of transaction

10 JULY 2009

If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:

17

Date of grant

18

Period during which or date on which it can be exercised

19

Total amount paid (if any) for grant of the option

20

Description of shares or debentures involved (class and number)

21

Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise

22

Total number of shares or debentures over which options are held following notification

23

Any additional information

N/A

24

Name of contact and telephone number for queries

 KAREN GEOGHEGAN (01-4637720)

Name and signature of duly designated officer of issuer responsible for making notification

_Karen Geoghegan___________________________________________________

Date of notification 13/07/2009

This announcement has been issued through the Companies Announcement Service of

the Irish Stock Exchange.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEUOOKRKSRBARR

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00